Africa: Two New Candidate Vaccines to Join Ebola Trial As Treatment Research Advances
Full story
World Health Organization expert groups recommended adding two new Ebola vaccine candidates to the Tumaini clinical trial. These trials are taking place in the Democratic Republic of the Congo. This is the first time vaccines designed for the Bundibugyo virus will be evaluated during an active outbreak.
[WHO] Expert groups convened by the World Health Organization (WHO) have recommended adding two new Ebola vaccine candidates to the ongoing Tumaini clinical trial in the Democratic Republic of the Congo (DRC). The recommendation marks the first time vaccines specifically designed to protect against Bundibugyo virus, the virus responsible for the current outbreak, will be evaluated during an outbreak of the disease.